Medindia

X

Ranbaxy, Aurobinda Pharma Applauded by Annan

by Medindia Content Team on  July 25, 2006 at 7:14 PM Drug News   - G J E 4
Ranbaxy, Aurobinda Pharma Applauded by Annan
India's Ranbaxy Laboratories and Aurobinda Pharma were among some of the world's leading pharmaceutical and diagnostic companies applauded by UN Secretary General Kofi Annan for their commitment to expand access to HIV/AIDS treatment and prevention.
Advertisement

Annan complimented these companies for their efforts in the field of HIV/AIDS treatment and prevention after a meeting with their top executives at United Nations Headquarters yesterday.

Advertisement
Beside Ranbaxy and Aurobinda Pharma, the participating companies included Aspen Pharmacare, Becton Dickinson, Bristol-Myers Squibb, GlaxoSmithKline, Hetero Drugs, Johnson & Johnson and Merck & Company.

"I am pleased that the companies I met today pledged to continue their efforts, in line with international commitments towards the goal of being as close as possible to universal access by 2010," Annan said.

Despite the significant advances in the five years since he first met with pharmaceutical company executives, Annan said the AIDS epidemic is "still outpacing our efforts and we need to work together in a broad partnership to step up the response." In that light, he said that the companies have committed individually to continue to review their product offerings and the prices of their existing and new HIV medications and diagnostics, especially for children, to make them more affordable, accessible and appropriate for use in low-and middle-income countries.

Source:PTI News
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions
sir inform me job applicable for b. tech biotech student
guest Monday, December 25, 2006

You May Also Like

Advertisement
View All

More News on: